Jump Financial, LLC

Position in RGNX — REGENXBIO Inc.

CIK 1831577 Chicago, IL

Position in RGNX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,871,606

+$1,021,395 QoQ

Shares Held

239,700

+8.6% QoQ

Ownership

0.363%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#34

of 163 holders

Holding Since

Sep 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Jump Financial, LLC holds $441,487,523 across 168 Biotechnology names. RGNX ranks #47 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	306,330	$24,288,904
2	VKTX	Viking Therapeutics, Inc.	579,882	$22,621,196
3	XENE	Xenon Pharmaceuticals Inc.	260,730	$15,737,662
4	CRSP	CRISPR Therapeutics AG	277,952	$15,159,500
5	BMRN	Biomarin Pharmaceutical Inc	245,390	$14,041,214
6	SRPT	Sarepta Therapeutics, Inc.	679,445	$12,209,626
7	REGN	Regeneron Pharmaceuticals, Inc.	16,242	$10,127,536
8	RARE	Ultragenyx Pharmaceutical Inc.	286,952	$9,581,327

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,871,606	239,700	+8.6%	Shares	Defined	2026-08-13
2026-03-31	$1,850,211	220,789	+24.0%	Shares	Defined	2026-05-14
2025-12-31	$2,563,560	178,025	+256.1%	Shares	Defined	2026-02-17
2025-09-30	$482,500	50,000	+64.3%	Shares	Defined	2025-11-13
2025-06-30	$249,781	30,424	-71.7%	Shares	Defined	2025-08-13
2025-03-31	$767,579	107,354	-44.3%	Shares	Defined	2025-05-14
2024-12-31	$1,489,630	192,708	+144.9%	Shares	Defined	2025-02-13
2024-09-30	$825,593	78,703	+7.8%	Shares	Defined	2024-11-14
2024-06-30	$853,807	72,975	+103.4%	Shares	Defined	2024-11-14
2023-12-31	$643,937	35,874	-24.8%	Shares	Sole	2024-10-21
2023-06-30	$953,463	47,697	+46.3%	Shares	Sole	2024-10-21
2022-03-31	$1,081,994	32,600	+116.3%	Shares	Sole	2022-05-12
2021-09-30	$631,860	15,073	—	Shares	Sole	2021-11-12
No filing history on record for this holder in this stock.